1366 related articles for article (PubMed ID: 25819852)
1. Rationale and design of a study exploring the efficacy of once-daily oral rivaroxaban (X-TRA) on the outcome of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation or atrial flutter and a retrospective observational registry providing baseline data (CLOT-AF).
Lip GY; Hammerstingl C; Marin F; Cappato R; Meng IL; Kirsch B; Morandi E; van Eickels M; Cohen A
Am Heart J; 2015 Apr; 169(4):464-71.e2. PubMed ID: 25819852
[TBL] [Abstract][Full Text] [Related]
2. Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF).
Lip GY; Hammerstingl C; Marin F; Cappato R; Meng IL; Kirsch B; van Eickels M; Cohen A;
Am Heart J; 2016 Aug; 178():126-34. PubMed ID: 27502860
[TBL] [Abstract][Full Text] [Related]
3. Outcome of non-vitamin K oral anticoagulants in the treatment of left atrial/left atrial appendage thrombus in patients with nonvalvular atrial fibrillation.
Lin C; Quan J; Bao Y; Hua W; Ke M; Zhang N; Jin Q; Xie Y; Wei Y; Ling T; Pan W; Wu L; Xie Y
J Cardiovasc Electrophysiol; 2020 Mar; 31(3):658-663. PubMed ID: 31975470
[TBL] [Abstract][Full Text] [Related]
4. Rationale and design of the eXplore the efficacy and safety of once-daily oral riVaroxaban for the prEvention of caRdiovascular events in patients with nonvalvular aTrial fibrillation scheduled for cardioversion trial: A comparison of oral rivaroxaban once daily with dose-adjusted vitamin K antagonists in patients with nonvalvular atrial fibrillation undergoing elective cardioversion.
Ezekowitz MD; Cappato R; Klein AL; Camm AJ; Ma CS; Le Heuzey JY; Talajic M; Scanavacca MI; Vardas PE; Kirchhof P; Hohnloser SH; Hemmrich M; Lanius V; Meng IL; Wildgoose P; van Eickels M
Am Heart J; 2014 May; 167(5):646-52. PubMed ID: 24766973
[TBL] [Abstract][Full Text] [Related]
5. [Effect of non-vitamin K antagonist oral anticoagulants on left atrial or atrial appendage thrombi in patients with nonvalvular atrial fibrillation].
Cui J; Du X; Wu JH; Jia CQ; Li X; Ning M; Lyu J; Yang Y; Liu XH; Dong JZ; Ma CS
Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Aug; 46(8):606-610. PubMed ID: 30139010
[No Abstract] [Full Text] [Related]
6. Left atrial thrombus resolution in non-valvular atrial fibrillation or flutter: biomarker substudy results from a prospective study with rivaroxaban (X-TRA).
Miyazawa K; Pastori D; Hammerstingl C; Cappato R; Meng IL; Kramer F; Cohen A; Schulz A; Eickels MV; Lip GYH; Marin F
Ann Med; 2018 Sep; 50(6):511-518. PubMed ID: 29956554
[TBL] [Abstract][Full Text] [Related]
7. Non-vitamin K oral anticoagulants versus warfarin for left atrial appendage thrombus resolution in nonvalvular atrial fibrillation or flutter.
Hussain A; Katz WE; Genuardi MV; Bhonsale A; Jain SK; Kancharla K; Saba S; Shalaby AA; Voigt AH; Wang NC
Pacing Clin Electrophysiol; 2019 Sep; 42(9):1183-1190. PubMed ID: 31355470
[TBL] [Abstract][Full Text] [Related]
8. Transesophageal vs. intracardiac echocardiographic screening in patients undergoing atrial fibrillation ablation with uninterrupted rivaroxaban.
Tsyganov A; Shapieva A; Sandrikov V; Fedulova S; Mironovich S; Dzeranova A; Lyan E
BMC Cardiovasc Disord; 2017 Jun; 17(1):171. PubMed ID: 28662693
[TBL] [Abstract][Full Text] [Related]
9. Assessment and Management of the Left Atrial Appendage Thrombus in Patients With Nonvalvular Atrial Fibrillation.
Zhan Y; Joza J; Al Rawahi M; Barbosa RS; Samuel M; Bernier M; Huynh T; Thanassoulis G; Essebag V
Can J Cardiol; 2018 Mar; 34(3):252-261. PubMed ID: 29395705
[TBL] [Abstract][Full Text] [Related]
10. Left atrial appendage emptying fraction assessed by a feature-tracking echocardiographic method is a determinant of thrombus in patients with nonvalvular atrial fibrillation.
Iwama M; Kawasaki M; Tanaka R; Ono K; Watanabe T; Hirose T; Nagaya M; Noda T; Watanabe S; Minatoguchi S
J Cardiol; 2012 May; 59(3):329-36. PubMed ID: 22342529
[TBL] [Abstract][Full Text] [Related]
11. Rationale and design of the RE-LATED AF--AFNET 7 trial: REsolution of Left atrial-Appendage Thrombus--Effects of Dabigatran in patients with Atrial Fibrillation.
Ferner M; Wachtlin D; Konrad T; Deuster O; Meinertz T; von Bardeleben S; Münzel T; Seibert-Grafe M; Breithardt G; Rostock T
Clin Res Cardiol; 2016 Jan; 105(1):29-36. PubMed ID: 26109251
[TBL] [Abstract][Full Text] [Related]
12. Resolution of left ventricular thrombus by rivaroxaban.
Padilla Pérez M; Salas Bravo D; Garcelán Trigo JA; Vazquez Ruiz de Castroviejo E; Torres Llergo J; Lozano Cabezas C; Fernández Guerrero JC
Future Cardiol; 2014 May; 10(3):333-6. PubMed ID: 24976470
[TBL] [Abstract][Full Text] [Related]
13. Identification of Left Atrial Appendage Thrombi in Patients With Persistent and Long-Standing Persistent Atrial Fibrillation Using Intra-Cardiac Echocardiography and Cardiac Computed Tomography.
Ikegami Y; Tanimoto K; Inagawa K; Shiraishi Y; Fuse J; Sakamoto M; Momiyama Y; Takatsuki S
Circ J; 2017 Dec; 82(1):46-52. PubMed ID: 28740038
[TBL] [Abstract][Full Text] [Related]
14. Left atrial thrombus and dense spontaneous echocardiographic contrast in patients on continuous direct oral anticoagulant therapy undergoing catheter ablation of atrial fibrillation: Comparison of dabigatran, rivaroxaban, and apixaban.
Wu M; Gabriels J; Khan M; Shaban N; D'Amato S; Liu CF; Markowitz SM; Ip JE; Thomas G; Singh P; Lerman B; Patel A; Cheung JW
Heart Rhythm; 2018 Apr; 15(4):496-502. PubMed ID: 29605015
[TBL] [Abstract][Full Text] [Related]
15. Left atrial appendage closure followed by 6 weeks of antithrombotic therapy: a prospective single-center experience.
Chun KR; Bordignon S; Urban V; Perrotta L; Dugo D; Fürnkranz A; Nowak B; Schmidt B
Heart Rhythm; 2013 Dec; 10(12):1792-9. PubMed ID: 23973952
[TBL] [Abstract][Full Text] [Related]
16. Role of oral anticoagulation and inoue balloon mitral valvulotomy in presence of left atrial thrombus: a prospective serial transesophageal echocardiographic study.
Kandpal B; Garg N; Anand KV; Kapoor A; Sinha N
J Heart Valve Dis; 2002 Jul; 11(4):594-600. PubMed ID: 12150310
[TBL] [Abstract][Full Text] [Related]
17. NOACs and atrial fibrillation: Incidence and predictors of left atrial thrombus in the real world.
Bertaglia E; Anselmino M; Zorzi A; Russo V; Toso E; Peruzza F; Rapacciuolo A; Migliore F; Gaita F; Cucchini U; De Divitiis M; Iliceto S; Stabile G
Int J Cardiol; 2017 Dec; 249():179-183. PubMed ID: 29121724
[TBL] [Abstract][Full Text] [Related]
18. Left Atrial or Left Atrial Appendage Thrombus Resolution After Adjustment of Oral Anticoagulant Treatment.
Lee WC; Fang CY; Chen YL; Fang HY; Chen HC; Liu WH; Fu M; Chen MC
J Stroke Cerebrovasc Dis; 2019 Jan; 28(1):90-96. PubMed ID: 30301596
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of rivaroxaban on the resolution of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation patients.
Ke HH; He Y; Lv XW; Zhang EH; Wei Z; Li JY
J Thromb Thrombolysis; 2019 Aug; 48(2):270-276. PubMed ID: 31165950
[TBL] [Abstract][Full Text] [Related]
20. Pre- and post-cardioversion transesophageal echocardiography for brief anticoagulation therapy with enoxaparin in atrial fibrillation patients: a prospective study with a 1-year follow-up.
de Luca I; Sorino M; De Luca L; Colonna P; Del Salvatore B; Corlianò L
Int J Cardiol; 2005 Jul; 102(3):447-54. PubMed ID: 16004890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
